Peripartum cardiomyopathy

Critical Care Medicine

Volumn 33, Issue 10 SUPPL., 2005, Pages

  Murali, Srinivas ^a   Baldisseri, Marie R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Acute inflammatory myocarditis; Angiotensin converting enzyme inhibitors; Dilated cardiomyopathy; Endomyocardial biopsy; Gestational hypertension; Implantable defibrillators; Left ventricular systolic dysfunction; Twin pregnancies

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; GLYCERYL TRINITRATE; HEPARIN; HYDRALAZINE; IMMUNOMODULATING AGENT; ISOSORBIDE DINITRATE; MILRINONE; NITROPRUSSIDE SODIUM; PENTOXIFYLLINE; SOTALOL; WARFARIN;

ADOLESCENT; ADULT; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HIGH RISK PREGNANCY; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MYOCARDITIS; PERINATAL PERIOD; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; TWIN PREGNANCY;

EID: 26444457255     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000183500.47273.8E     Document Type: Review

References (46)

1. Gouley BA, McMillan TM, Bellet S: Idiopathic myocardial degeneration associated with pregnancy and especially the peripartum. Am J Med Sci 1937; 19:185-199
2. Demakis JG, Rahimtoola SH, Sutton GC, et al: Natural course of peripartum cardiomyopathy. Circulation 1971; 44:1053-1061
3. Whitehead SJ: Pregnancy-related mortality due to cardiomyopathy: United States, 1991-1997. Obstet Gynecol 2003; 102:1326-1331
4. Seftel H, Susser M: Maternity and myocardial failure in African women. Br Heart J 1961; 23:43-52
5. Fett JD, Carraway RD, Dowell DL, et al: Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol 2002; 186:1005-1010
6. Baughman KL: Peripartum cardiomyopathy. Curr Treat Options Cardiovasc Med 2001; 3:469-480
7. Lang RM, Lampert MB, Poppas A, et al: Peripartal cardiomyopathy. In: Cardiac Problems in Pregnancy. 3rd ed. Elkayam U, Gleicher N (Eds). New York, NY, Wiley-Liss, 1998, pp 87-100
8. Lampert MB, Lang RM: Peripartum cardiomyopathy. Am Heart J 1995; 130:860-870
9. Elkayam U, Akhter MW, Singh H, et al: Pregnancy-associated cardiomyopathy: A clinical comparison between early and late presentation. Circulation 2005; 111:2050-2055
10. O'Connell JB, Costanzo-Nordin MR, Subramanian R, et al: Peripartum cardiomyopathy: Clinical hemodynamic, histologic and prognostic characteristics. J Am Coll Cardiol 1986; 8:52-56
11. Ansari AA, Fett JD, Carraway RE, et al: Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol 2002; 23:310-324
12. Ansari AA, Neckelmann N, Wang YC, et al: Immunologic dialogue between cardiac myocytes, endothelial cells, and mononuclear cells. Clin Immunol Immunopathol 1993; 68:208-214
13. Fett JD, Ansari AA, Sundstrom JB, et al: Peripartum cardiomyopathy: A selenium disconnection and an autoimmune connection. Int J Cardiol 2002; 86:311-316
14. Midei MG, DeMent SH, Feldman AM, et al: Peripartum myocarditis and cardiomyopathy. Circulation 1990; 81:922-928
15. Rizeq MN, Rickenbacher PR, Fowler MB, et al: Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol 1994; 74:474-477
16. Felker GM, Thompson RE, Hare JM, et al: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342:1077-1084
17. Hogle KL, Hutton EK, McBrien KA, et al: Cesarean delivery for twins: A systematic review and meta-analysis. Am J Obstet Gynecol 2003; 188:220-227
18. Pearson GD, Veille JC, Rahimtoola S, et al: Peripartum cardiomyopathy: National Heart, Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) Workshop recommendations and review. JAMA 2000; 283:1183-1188
19. Warraich RS, Sliwa K, Damasceno A, et al: Impact of pregnancy-related heart failure as humoral immunity: Clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. Am Heart J 2005; 150:263-269
20. Beauchesne LM, Connelly HM, Ammash NM, et al: Coarctation of the aorta: Outcome of pregnancy. J Am Coll Cardiol 2001; 38:1728-1733
21. Lampert MB, Hibbard J, Weinert L, et al: Peripartum heart failure associated with prolonged tocolytic therapy. Am J Obstet Gynecol 1993; 168:493-495
22. Phillips SD, Warnes CA: Peripartum cardiomyopathy: Current therapeutic perspectives. Curr Treat Options Cardiovasc Med 2004; 6:481-488
23. Sliwa K, Skudicky D, Bergemann A, et al: Peripartum cardiomyopathy: Analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 2000; 35:701-705
24. Dorbala S, Brozena S, Zeb S, et al: Risk stratification of women with peripartum cardiomyopathy at initial presentation: A dobutamine stress echocardiography study. J Am Soc Echocardiogr 2005; 18:45-48
25. Elkayam U, Tummala P, Rao K, et al: Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001; 344:1567-1571
26. Sutton MSJ, Cole P, Plappert M, et al: Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Am Heart J 1991; 121:1776-1778
27. Stevenson LW: Rapid assessment of hemodynamic status in acute decompensated heart failure. Eur J Heart Failure 1999; 1:251-257
28. Fonarow GC. The treatment targets in acute decompensated heart failure. Rev Cardiovasc Med 2001; 2(Suppl):S7-S12
29. Fonarow GC, Gheorghiade M, Abraham WT: Importance of in-hospital initiation of evidence-based medical therapies for heart failure: A review. Am J Cardiol 2004; 94:1155-1160
30. Fonarow GC. Nesiritide: Practical guide to its safe and effective use. Rev Cardiovasc Med 2001; 2(Suppl):S32-S35
31. Brozena SC, Twomey C, Goldberg LR, et al: A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplantation. J Heart Lung Transplant 2004; 23:1082-1086
32. Leier CV: Advanced heart failure: A practical management algorithm and therapeutic options. Am Heart Hosp J 2004; 2:142-148
33. Hunt SA, et al: ACC/AHA guidelines for the management of chronic heart failure in the adult: Executive summary. J Am Coll Cardiol 2001; 38:2101-2113
34. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-691
35. Shotan A, Widerhorn J, Hurst A, et al: Risks of angiotensin-converting enzyme inhibitors during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 1994; 96:451-456
36. Cohn JN, Johnson G, Ziesche S, et al: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325:303-310
37. Geha RS: Regulation of the immune response by idiotypic-anti-idiotypic interactions. N Engl J Med 1981; 305:25-28
38. Thornton CA, Griggs RC: Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann Neurol 1994; 35:260-268
39. Bozkurt B, Villaneuva FS, Holubkov R, et al: Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 1999; 34:177-180
40. McNamara DM, Holubkov R, Starling RC, et al: Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001; 103:2254-2259
41. Mason JW, O'Connell JB, Herskowitz A, et al: A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333:269-275
42. Aziz TM, Burgess MI, Acladious NN, et al: Heart transplantation for peripartum cardiomyopathy: A report of three cases and a literature review. Cardiovasc Surg 1999; 7:565-567
43. Rickenbacher PR, Rizeq MN, Hunt SA, et al: Long-term outcome after heart transplantation for peripartum cardiomyopathy. Am Heart J 1994: 127;1318-1323
44. Taylor AL, Ziesche S, Yancy C, et al, for African-American Heart Failure Trial Investigators: Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 2004; 351:2049-2057
45. Sliwa K, Skudicky D, Candy G, et al: The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 2002; 4:305-309
46. Jessup M, Brozena S: Heart failure. N Engl J Med 2003; 348:2007-2018.